基因治疗

jī yīn zhì liáo
  • gene therapy;genetic therapy
基因治疗基因治疗
  1. 其中基因治疗的靶向性是值得密切关注的问题之一。

    The targeting of gene therapy has been paid close attention .

  2. 血友病B基因治疗临床试验的安全性研究

    Safety assessments required for animal test and preclinical trial of hemophilia B gene therapy

  3. 基因治疗新策略&酶性DNA的设计和应用

    New strategy in the gene therapy : design and application of catalytic DNA

  4. CT导引下肝细胞生长因子基因治疗脑缺血的实验研究

    The experimental study of CT-guided hepatocyte growth factor gene therapy for cerebral ischemic diseases

  5. 非小细胞肺癌p53基因治疗的循证医学评价

    Evidence-based Appraisal of p53 Gene Therapy for Non-Small Cell Lung Cancer

  6. 腺病毒介导胞嘧啶脱氨酶(CD)基因治疗胰腺癌的实验研究

    Adenovirus-Mediated Cytosine Deaminase ( CD ) Gene Transfer in the Treatment of Pancreatic Cancer

  7. 腺病毒介导th基因治疗帕金森病

    Adenovirus-Mediated th Gene Therapy of Parkinson 's Disease in Experimental Rat Model

  8. 目的:探讨白细胞介素7裸DNA质粒用于小鼠肿瘤基因治疗的可行性。

    Objective : To investigate the possibility of gene therapy with naked plasmid encoding interleukin 7 ( IL 7 ) .

  9. 利用bcl-2基因治疗慢性充血性心力衰竭的实验研究

    The Experimental Studies on Treating Chronic Congestive Heart Failure Using bcl-2 Gene

  10. AIDS基因治疗策略

    Gene Therapy Strategies for AIDS

  11. 目的研究仙台病毒载体复制序列对未成熟树突状细胞(Dendriticcells,DC)蛋白质表达的影响,为联合运用二者进行基因治疗提供依据。

    Objective To investigate the protein change in immature dendritic cells ( DC ) exposed to sendai virus replication sequence .

  12. 结论腺病毒介导的p53基因治疗能有效控制肝癌的生长。

    Conclusions Replication-deficient adenoviral vector expressing WT-p53 may be useful for gene therapy of HCC .

  13. IL-2和IL-12联合基因治疗小鼠肝癌的实验研究

    Gene therapy with IL-2 and IL-12 for murine hepatocellular carcinoma

  14. 自杀基因治疗鼠C6脑胶质瘤模型的动态MRI研究

    The Therapeutic Effect of Suicide Gene on Rat C6 Glioma Model Dynamic Observation with HR MRI

  15. 目的探讨乙型肝炎病毒(HBV)作为肝靶向性基因治疗载体的可能性。

    Objective To evaluate the possibility of hepatitis B virus ( HBV ) as a vector in liver-targeting gene therapy .

  16. HIVVpr蛋白应用于特异性肝癌基因治疗的研究

    Study on the Application of HIV Vpr to Specific Hepatoma Gene Therapy

  17. 用COX一2启动子构建的重组载体需经合理修饰后才可用于卵巢癌的基因治疗。

    With proper modification , COX-2 promoter is useful in gene therapy of ovarian cancers .

  18. 目的初步观察动脉灌注p53基因治疗晚期肝癌的疗效。

    Objective To preliminarily investigate curative effect of hepatic arterial perfusion of p53 gene in the therapy of advanced hepatocellular carcinoma .

  19. 将来可能包括基因治疗,MMP调节剂和抑制剂,PDT。

    Future could include gene therapy , MMP regulators and inhibitors , PDT .

  20. 这些发现使这套DNA载体介导的RNA干扰表达系统能够在功能基因组研究方面广泛发挥作用,并有望成为基因治疗大家族中重要的一员。

    These findings highlight the general utility of this DNA vector-based RNAi technology in suppression gene suppression gene expression in mammalian cells and the applications in gene therapy .

  21. 细胞色素P450与肿瘤的基因治疗

    Cytochrome P450 and Cancer Gene Therapy

  22. 针对VEGF的抗肿瘤血管生成的治疗已取得了很大进展,包括应用VEGF抑制剂、腺病毒介导的基因治疗等。

    The anti-angiogenesis treatments aimed at VEGF , including the applications of VEGF inhibitor and gene therapy of adenovirus medium , had got great progress .

  23. 联合反义缺氧诱导因子-1α与B7-1基因治疗肿瘤的实验研究

    Antisense hypoxia inducible factor-1 α and B7-1 combination gene therapy for mouse lymphoma

  24. 目的构建pcmGMCSF重组质粒载体,为mGMCSF基因治疗肿瘤的研究奠定基础。

    Objective To construct recombiant plasmid pc-mGM-CSF and lay a primary foundation for further study of mGM-CSF gene therapy for tumors .

  25. 目的构建人白介素24(hIL24)的腺病毒载体,获得hIL24重组腺病毒子,为hIL24进行肿瘤的基因治疗奠定基础。

    Objective The recombinant adenovirus vector of hIL-24 was constructed for carcinoma gene therapy .

  26. 基因治疗有望成为治疗AITD的一种新途径。

    Gene therapy is a new and promising way to cure AITD .

  27. 结论:1.Survivin在k562细胞中高表达,可作为白血病基因治疗的靶点;

    Conclusions 1 . The protein level of survivin in k562 cells is high . Survivin may be a new target of leukemia gene therapy .

  28. 深入了解并阐明HSP的发病机制对寻求新的免疫学和未来的基因治疗十分重要。

    A deeper understanding and illustration of HSP 's pathogenesis are very important for searching new immunology and future gene therapy .

  29. 本研究为IL-15为基础的肿瘤免疫基因治疗的临床应用提供了实验依据。

    Therefore , this study provides evidence for the clinical application of IL-15 base gene therapy .

  30. 结论靶向EGFR的siRNA表达载体可以特异性地抑制EGFR的表达,可以成为胶质瘤靶向性EGFR基因治疗的一种新策略。

    Conclusion The siRNA expression constructs targeting EGFR could specifically inhibit EGFR expression , and should be a new strategy in glioma gene therapy targeting EGFR .